Haanen JBAG - Search Results

1

Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.

Verver D, Grünhagen DJ, van Akkooi ACJ, Aarts MJB, van den Berkmortel FWPJ, van den Eertwegh AJM, de Groot JWB, Boers-Sonderen MJ, Haanen JBAG, Hospers GAP, Kapiteijn E, Piersma D, van Rijn RS, Suijkerbuijk KPM, Tije AJT, Vreugdenhil G, Verhoef C, van der Veldt AAM. Verver D, et al. Among authors: haanen jbag. Cancer Immunol Immunother. 2021 Nov;70(11):3123-3135. doi: 10.1007/s00262-021-02871-1. Epub 2021 Mar 27. Cancer Immunol Immunother. 2021. PMID: 33774697 Free PMC article.

2

A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor.

Bex A, Mallo H, Kerst M, Haanen J, Horenblas S, de Gast GC. Bex A, et al. Cancer Immunol Immunother. 2005 Jul;54(7):713-9. doi: 10.1007/s00262-004-0630-9. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627213 Free PMC article. Clinical Trial.

3

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.

Smit LH, Korse CM, Hart AA, Bonfrer JM, Haanen JB, Kerst JM, Nieweg OE, de Gast GC. Smit LH, et al. Eur J Cancer. 2005 Feb;41(3):386-92. doi: 10.1016/j.ejca.2004.10.019. Eur J Cancer. 2005. PMID: 15691637

4

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.

Kerst JM, Bex A, Mallo H, Dewit L, Haanen JB, Boogerd W, Teertstra HJ, de Gast GC. Kerst JM, et al. Cancer Immunol Immunother. 2005 Sep;54(9):926-31. doi: 10.1007/s00262-005-0677-2. Epub 2005 May 19. Cancer Immunol Immunother. 2005. PMID: 15906025 Free PMC article. Clinical Trial.

5

Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.

Haanen JB, Baars A, Gomez R, Weder P, Smits M, de Gruijl TD, von Blomberg BM, Bloemena E, Scheper RJ, van Ham SM, Pinedo HM, van den Eertwegh AJ. Haanen JB, et al. Cancer Immunol Immunother. 2006 Apr;55(4):451-8. doi: 10.1007/s00262-005-0018-5. Epub 2005 Jul 21. Cancer Immunol Immunother. 2006. PMID: 16034562 Free PMC article. Clinical Trial.

6

[Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus].

de Mulder PH, Haanen JB, Sleijfer S, Kruit WH, Gietema JA, Richel DJ, Groenewegen G, Voest EE, van den Eertwegh AJ, Osanto S, Jansen RL, Mulders PF. de Mulder PH, et al. Ned Tijdschr Geneeskd. 2008 Feb 16;152(7):371-5. Ned Tijdschr Geneeskd. 2008. PMID: 18380383 Review. Dutch.

7

Sunitinib for treatment of advanced renal cell cancer: primary tumor response.

van der Veldt AA, Meijerink MR, van den Eertwegh AJ, Bex A, de Gast G, Haanen JB, Boven E. van der Veldt AA, et al. Clin Cancer Res. 2008 Apr 15;14(8):2431-6. doi: 10.1158/1078-0432.CCR-07-4089. Clin Cancer Res. 2008. PMID: 18413834

8

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.

van der Veldt AA, Boven E, Helgason HH, van Wouwe M, Berkhof J, de Gast G, Mallo H, Tillier CN, van den Eertwegh AJ, Haanen JB. van der Veldt AA, et al. Br J Cancer. 2008 Jul 22;99(2):259-65. doi: 10.1038/sj.bjc.6604456. Epub 2008 Jul 1. Br J Cancer. 2008. PMID: 18594533 Free PMC article. Clinical Trial.

9

Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.

van Cruijsen H, van der Veldt AA, Vroling L, Oosterhoff D, Broxterman HJ, Scheper RJ, Giaccone G, Haanen JB, van den Eertwegh AJ, Boven E, Hoekman K, de Gruijl TD. van Cruijsen H, et al. Clin Cancer Res. 2008 Sep 15;14(18):5884-92. doi: 10.1158/1078-0432.CCR-08-0656. Clin Cancer Res. 2008. PMID: 18794101

10

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery.

Bex A, van der Veldt AA, Blank C, van den Eertwegh AJ, Boven E, Horenblas S, Haanen J. Bex A, et al. World J Urol. 2009 Aug;27(4):533-9. doi: 10.1007/s00345-008-0368-7. Epub 2009 Jan 15. World J Urol. 2009. PMID: 19145434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters